Purchase Order 75N93019P00725
Award Date 6/27/19
Potential Completion Date 7/4/20
Potential Value $238K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents. The $101,340.96 contract provides a one-year service plan for Illumina's NextSeq and MiSeq sequencing platforms, as well as an iSeq 100 system, to be used at an NIAID facility in Frederick, Maryland. The contract was...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded Illumina, Inc., a manufacturer of sequencing and array-based solutions, a firm fixed-price purchase order for the maintenance and service of Illumina equipment, including NextSeq 2000, MiSeq, and iSeq 100 sequencing systems, with a potential value of $208,172.00. The contract has a period of performance from March 1, 2023, to February 28, 2026, and was awarded...
- This is a $189,332.15 firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis instruments and reagents. The contract provides an annual service agreement for four Illumina sequencing instruments, including preventative maintenance, parts, labor, reagent replacement, and technical...
- The Department of Health and Human Services, National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and genomic analysis equipment, for a maintenance/service agreement on three NextSeq 550 and two MiSeq sequencing systems. The $164,807.64 contract has a completion date of February 29, 2024 and will provide priority response for maintenance and repairs on this...
- The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded a $53,029.50 firm-fixed price purchase order to Illumina, Inc. for a one-year service plan covering preventative maintenance, full parts and labor coverage, reagent replacement, remote technical support, and software/hardware updates for the agency's Illumina NextSeq 2000 sequencing equipment at their Laboratory of Viral Diseases. This purchase was made under full and...
- This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer and provider of genetic and genomic analysis solutions. The $5,834.40 order is for the provision of Illumina's sequencing instruments, reagents, and services, including NextSeq, NovaSeq, MiSeq, and iSeq systems. These products and services support genomic sequencing and analysis for...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,250.00 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis solutions. The 12-month service contract, with a period of performance from April 1, 2019 through March 31, 2020, is for Illumina's MiSeq sequencing system and related services. This award is not associated with a larger...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $17,529.31 firm fixed price delivery order contract to Illumina, Inc. of San Diego, California. The contract is for Illumina brand consumables to support genomic sequencing and analysis. As the sole manufacturer of the sequencing instruments in use, Illumina will provide reagents and supplies for its NextSeq, NovaSeq, MiSeq, and iSeq platforms. No set-aside...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents, for $105,341.32. The order includes various sequencing products such as the NovaSeq 6000 S2 Reagent Kit, NovaSeq XP 2-Lane Kit, MiSeq Reagent Kit V2, and Nextera XT DNA Library Preparation Kit to support life science research, applied...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc. to provide an Illumina NextSeq 550 sequencing system. The potential value of the contract is $273,655.08. There was no set-aside designation for this award. Illumina, a for-profit manufacturer of genetic and genomic analysis instruments and reagents, has provided a range of sequencing systems and related...